You are here

HIGH-THROUGHPUT FLUORESCENT PROTEIN KINASE ASSAYS

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43GM066439-01
Agency Tracking Number: GM066439
Amount: $100,110.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2002
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
ECHELON BIOSCIENCES, INC. 420 CHIPETA WAY, STE 180
SALT LAKE CITY, UT 84108
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 MICHAEL MOSTERT
 (801) 588-0455
 MMOSTERT@ECHELON-INC.COM
Business Contact
 THOMAS HEATH
Phone: (801) 588-0455
Email: GTHEATH@ECHELON-INC.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): Protein kinases catalyze the phosphorylation of serine (Ser), threonine (Thr), and tyrosine (Tyr) residues in peptides and proteins, and comprise the largest superfamily of enzymes in eukaryotes with an estimated 500 genes in the human genome. Because most intracellular processes are regulated by protein phosphorylation, dysregulation of protein kinases can lead to a variety of disease states. Protein kinases are therefore important targets for drug discovery and development. Protein kinase-targeted drug discovery requires the ability to rapidly screen compounds for their ability to specifically inhibit selected protein kinases. To facilitate the high-throughput screening of kinase activities we will develop microplate protein kinase assays using a proprietary fluorescence technology developed at the University of Utah. First, we will prepare two sets of fluorescently labeled synthetic peptides. One set will be used to assay protein Ser/Thr kinases, the other for protein Tyr kinases. Second, we will optimize each protein kinase assay system for use in standard 96-well and 384-well fluorescence microplate readers. Based on feedback from outside evaluators, we will optimize and develop commercial versions of these protein kinase assay kits to be sold to the research community and companies involved in drug discovery and development.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government